Imagilin Technology Overview

  • Founded
  • 2003
  • Status
  • Private
  • Employees
  • 1
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $85.5K
Latest Deal Amount
  • Investors
  • 2

Imagilin Technology General Information


Provider of dietary supplements. The company develops probiotics as therapeutic agents to fight against stress and autoimmune diseases in humans and animals.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Food Products
Other Industries
Other Healthcare
Primary Office
  • 93 Monocacy Boulevard
  • Suite A9
  • Frederick, MD 21701
  • United States
+1 (301) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Imagilin Technology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator 08-Feb-2012 $85.5K 00000 Completed Startup
1. Early Stage VC 10-Jun-2009 0000 0000 Completed Startup
To view Imagilin Technology’s complete valuation and funding history, request access »

Imagilin Technology Executive Team (1)

Name Title Board Seat Contact Info
Jhy-Jhu Lin Ph.D Founder & Chief Scientist
To view Imagilin Technology’s complete executive team members history, request access »

Imagilin Technology Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Imagilin Technology Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Maryland Industrial Partnerships University Minority 000 0000 000000 0
TEDCO Venture Capital Minority 000 0000 000000 0
To view Imagilin Technology’s complete investors history, request access »